NEPC Trial PD-1 Inhibition in Neuroendocrine-like Prostate Cancer (PD-1 Inhibition or Combination Checkpoint Immuntherapy of Neuroedocrine_Like Prostate Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
October 26, 2017
End Date
June 30, 2022
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
October 26, 2017
End Date
June 30, 2022